What type of companies cannot be valued using the standard DCF model?

Just want to hearing other industry experts' opinions on what types of companies are not value-able using the standard DCF model (FCF-based). Currently I have the following:

  1. Banks (driven by loans/deposits)
  2. Insurance companies (driven by written premiums and claims)
  3. Private equities/other balance-sheet-based financial companies (driven by proprietary investments)
  4. REITs (driven by property assets)
  5. Business development companies (driven by value of portfolio companies)
  6. Biopharma (can't assign terminal value to patents, need multiple DCF to value different drugs)
  7. Mining (finite value dependent on individual mines)
  8. Oil & gas (finite value depended on oil/gas reserves)
  9. Utilities (regulated ROI)

Are these correct and are there any other type of companies that can't be valued using the standard DCF model?

 

Every industry is going to have some modified version of DCF that can value the business you're looking at.

I've valued REITs, O&G, pharma, banks using DCFs. It's just not the fastest way to do it. If your assumptions are consistent, you will end up with the same result.

 

Consequatur repellendus possimus explicabo quibusdam corporis quod. Placeat ea dolores atque quia. Eos nisi iusto est omnis eos nemo corporis. Dolorem laboriosam et nobis inventore in. Incidunt ea corporis pariatur repudiandae.

Career Advancement Opportunities

May 2024 Investment Banking

  • Jefferies & Company 02 99.4%
  • Goldman Sachs 19 98.8%
  • Harris Williams & Co. New 98.3%
  • Lazard Freres 02 97.7%
  • JPMorgan Chase 04 97.1%

Overall Employee Satisfaction

May 2024 Investment Banking

  • Harris Williams & Co. 18 99.4%
  • JPMorgan Chase 10 98.8%
  • Lazard Freres 05 98.3%
  • Morgan Stanley 07 97.7%
  • William Blair 03 97.1%

Professional Growth Opportunities

May 2024 Investment Banking

  • Lazard Freres 01 99.4%
  • Jefferies & Company 02 98.8%
  • Goldman Sachs 17 98.3%
  • Moelis & Company 07 97.7%
  • JPMorgan Chase 05 97.1%

Total Avg Compensation

May 2024 Investment Banking

  • Director/MD (5) $648
  • Vice President (19) $385
  • Associates (88) $260
  • 3rd+ Year Analyst (14) $181
  • Intern/Summer Associate (33) $170
  • 2nd Year Analyst (67) $168
  • 1st Year Analyst (205) $159
  • Intern/Summer Analyst (146) $101
notes
16 IB Interviews Notes

“... there’s no excuse to not take advantage of the resources out there available to you. Best value for your $ are the...”

Leaderboard

success
From 10 rejections to 1 dream investment banking internship

“... I believe it was the single biggest reason why I ended up with an offer...”